Related Experiment Video
Updated: Aug 19, 2026

Stimulation of Notch Signaling in Mouse Osteoclast Precursors
Published on: February 28, 2017
Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiation
Alka Mansukhani1, Davide Ambrosetti, Greg Holmes
1Department of Microbiology, New York University School of Medicine, New York, NY 10016, USA. mansua01@med.nyu.edu
Abstract:
Activating mutations in fibroblast growth factor receptor 2 (FGFR2) cause several craniosynostosis syndromes by affecting the proliferation and differentiation of osteoblasts, which form the calvarial bones. Osteoblasts respond to FGF with increased proliferation and inhibition of differentiation. We analyzed the gene expression profiles of osteoblasts expressing FGFR2 activating mutations (C342Y or S252W) and found a striking down-regulation of the expression of many Wnt target genes and a concomitant induction of the transcription factor Sox2. Most of these changes could be reproduced by treatment of osteoblasts with exogenous FGF. Wnt signals promote osteoblast function and regulate bone mass. Sox2 is expressed in calvarial osteoblasts in vivo and we show that constitutive expression of Sox2 inhibits osteoblast differentiation and causes down-regulation of the expression of numerous Wnt target genes. Sox2 associates with beta-catenin in osteoblasts and can inhibit the activity of a Wnt responsive reporter plasmid through its COOH-terminal domain. Our results indicate that FGF signaling could control many aspects of osteoblast differentiation through induction of Sox2 and regulation of the Wnt-beta-catenin pathway.
Insights
Activating fibroblast growth factor receptor 2 (FGFR2) mutations disrupt bone development. FGF signaling induces Sox2, inhibiting osteoblast differentiation and Wnt pathway activity, impacting craniosynostosis syndromes.
Area of Science:
- Molecular Biology
- Developmental Biology
- Genetics
Background:
- Activating mutations in fibroblast growth factor receptor 2 (FGFR2) are linked to craniosynostosis syndromes.
- FGFR2 signaling influences osteoblast proliferation and differentiation, crucial for calvarial bone formation.
Purpose of the Study:
- To investigate the molecular mechanisms by which FGFR2 mutations affect osteoblast gene expression.
- To elucidate the role of Sox2 in mediating the effects of FGF signaling on osteoblast differentiation and Wnt pathway activity.
Main Methods:
- Gene expression profiling of osteoblasts with activating FGFR2 mutations (C342Y, S252W).
- Treatment of osteoblasts with exogenous FGF to mimic mutation effects.
- Analysis of Sox2 expression, osteoblast differentiation markers, and Wnt target gene activity.
- Co-immunoprecipitation to assess Sox2 and beta-catenin interaction.
Main Results:
- FGFR2 mutations and FGF treatment down-regulated Wnt target genes and induced Sox2 expression in osteoblasts.
- Constitutive Sox2 expression inhibited osteoblast differentiation and Wnt target gene expression.
- Sox2 associated with beta-catenin and inhibited Wnt pathway reporter activity.
Conclusions:
- FGF signaling regulates osteoblast differentiation, partly through Sox2 induction.
- Sox2 plays a critical role in suppressing osteoblast differentiation by interfering with the Wnt-beta-catenin pathway.
- These findings offer insights into the pathogenesis of FGFR2-related craniosynostosis syndromes.
Related Concept Videos
Canonical Wnt Signaling Pathway
Pleiotropy
Non-Canonical Wnt Signaling Pathways
TGF - β Signaling Pathway
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Hedgehog Signaling Pathway
